CIK 0001446847 · Accelerated filer<br>Smaller reporting company
IRONWOOD PHARMACEUTICALS INC
Sign in to watch- Ticker
- IRWD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043404176
- Phone
- 617-621-7722
- Business address
- 100 SUMMER STREET, SUITE 2300, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-11 | Silver Ronald Principal Accounting Officer | Sale | −2,846 | $0.84 | $2K | 276,809 |
| 2025-08-11 | Martini Gregory S. Chief Financial Officer | Sale | −1,265 | $0.84 | $1K | 182,545 |
| 2025-06-13 | DENNER ALEXANDER J Director | Grant or award | +24,193 | 235,962 | ||
| 2025-06-10 | Kessler Marla L Director | Grant or award | +45,000 | 165,883 | ||
| 2025-06-10 | Shepard Jay Director | Grant or award | +45,000 | 171,555 | ||
| 2025-06-10 | Moukheibir Catherine Director | Grant or award | +45,000 | 117,944 | ||
| 2025-06-10 | Duane Jon R Director | Grant or award | +45,000 | 190,339 | ||
| 2025-06-10 | Currie Mark G Director | Grant or award | +45,000 | 613,419 | ||
| 2025-06-10 | McHugh Julie Director | Grant or award | +45,000 | 208,839 | ||
| 2025-06-10 | Dreyfus Andrew Director | Grant or award | +45,000 | 228,313 | ||
| 2025-06-10 | DENNER ALEXANDER J Director | Grant or award | +45,000 | 211,769 | ||
| 2025-05-20 | MCCOURT Thomas A Chief Executive Officer | Grant or award | +540,000 | 1,687,281 | ||
| 2025-05-16 | MCCOURT Thomas A Chief Executive Officer | Sale | −13,353 | $0.58 | $8K | 1,147,281 |
| 2025-05-16 | Gaskins Tammi L Chief Commercial Officer | Sale | −2,563 | $0.58 | $1K | 242,596 |
| 2025-04-02 | DENNER ALEXANDER J Director | Grant or award | +10,416 | 166,769 | ||
| 2025-02-10 | MCCOURT Thomas A Chief Executive Officer | Sale | −139,064 | $1.76 | $245K | 1,160,634 |
| 2025-02-10 | Silver Ronald Principal Accounting Officer | Sale | −12,048 | $1.76 | $21K | 279,655 |
| 2025-02-10 | Shetzline Michael SVP, CMO, Head-Res&Drug | Grant or award | +133,333 | 595,276 | ||
| 2025-02-10 | Shetzline Michael SVP, CMO, Head-Res&Drug | Sale | −41,269 | $1.76 | $73K | 554,007 |
| 2025-02-10 | John Minardo Chief Legal Officer | Grant or award | +122,222 | 447,070 |
Page 3 of 7 · 128 trades